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iPSC vs ESC: 
A tale of two pluripotent cells
Gerard Llimós Aubach
Induced pluripotent stem cells (iPSC) are 
obtained from somatic cells by 
transcription factor reprogramming: 
Oct4, Sox2, Klf4 and c-Myc (Yamanaka’s 
cocktail). 
They have similar molecular and functional 
properties to embryonic stem cells (ESC). 
But , are they identically?
INTRODUCTION
Unfortunately, there are some variations between these two cell types that can affect the functionality of iPSC. Areas where we can find differences are 
morphology, proteome, transcriptome, epigenetics, genome and differentiation potential. The aim of this work is to discuss the most relevant variations reported 
recently and which are suposed to be the main causes of these changes.   
200 CNV/line. Most common around Nanog (Chr 12) and DNMT3B (Chr 20) 
(Human). Deletion of suppressor genes.
● Mutation by NHEJ and selected in vitro propagation (growth advantage).
● Causes: mainly source cell. 2% CNV due to in vitro culturing and replication 
stress.
● Stable and independent of reprogramming methodology.
● Differentiation potential not altered.
>1000 SNV/iPSC line (Human)
>100 SNV/iPSC line (Mouse)
● Mutation in exons: <12/iPSC line.
● Little important feature.
● Inherited from source cell.
DIFFERENTIAL CHARACTERISTICS
Chr 12, 8 and X (Human)
Chr 8 and 11 (Mouse)
● Growth advantage.
● Causes: source cell and in vitro 
culturing.
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STATE OF THE ARTCONCLUSION
 Epigenetics   Dlk1-Dio3 locus
There are differences between ESC and iPSC. They can have distinct origins: inherited from 
donor somatic cells, induced or selected by the reprogramming process or acummulated during 
culture passages. A lot of changes are not specific of iPSC because are also seen in ESC (all 
related to in vitro culturing). This suggests that reprogramming efficiency could rapidly increase 
with the improvement of medium cultures. Certain alterations can change iPSC properties and 
their derivatives:
These changes can be used to select bona fide iPSC which have undergone a perfect 
reprogramming. So, it is important to:
● Detect and monitor variations.
● Optimize reprogramming strategy and culture conditions.
Tumorigenesis Immunogenicity    Differentiation potential 
Database (like 
Pluritest for gene 
expression)
Fast
Exhaustive
Reliable
Cheap
● Genome-wide DNA 
sequencing
● RNA-seq microarray
● Bisulphite pirosequencing
● ChIP-chip and ChIP-seq
● Immunocytochemistry
Omics Pluripotency 
fingerprints
Bioinformatic 
tools
iPSC
screening 
miRNA 106a~363 and 290~295 clusters
+ miR-200c-3p
Single nucleotid variationAneuploidy
Copy number variation
Source cell memory
Epigenetics
● This locus is regulated by 
imprinting.
● Its silencing impedes mice 
development.
● Causes: in vitro culturing 
and reprogramming.
● Prevention: ascorbic acid in 
medium.
Stadtfeld M et al. Nature 2010; 
465:175–181.
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● Few differences in transcriptome.
● miRNA profile can distinguish the state of 
partially reprogrammed lines.
● Causes: reprogramming and in vitro 
culturing.
● More expressed in mESC than miPSC.
● Their downregulation is associated with low 
efficiency.
● miRNAs can be good pluripotency markers.
Epigenetics       X Chromosome
Transcriptome
Stadtfeld M et al. Nature 2010; 
465:175–181.
TMEM132C TMEM132D TCERG FZD10 DPP6 FAM19A5
● These genes commonly have different expression between hiPSC and hESC.
● Causes: culture and reprogramming.
Aberrant DNA methylation and histone modification
● Hypermethylation in CpG & CpG islands. Regions related to 
binding sites of TF KLF4 and FOXL1.
● Large-scale hotspots (100kb-1’3Mb) in subtelomeric regions 
caused by incomplet 5-hydroxymethylation. Culture induces the 
repressive histone modification H3K9m3 that blocks de novo 
methylation. Generally is a random process.
● Culture passages increase aberrant methylation in imprinted 
genes. Hypermethylation brings total silencing and hypomethylation 
produces loss of imprinting (LOI). 
Ruiz S et al. PNAS 2012; 109:16196–16201.
Papp B and Plath K. Cell 
2013; 152:1324-1343.
● In vitro culturing is 
tha main problem of 
X chr inactivation.
Transcriptome
Expression of tissue specific genes: unmethylated 
CpG, H3Ac and H3K4m3 (transcriptionally active).
Silencing of other genes: methylated CpG and 
H3K27m3 (repressor factors).
● Memory loss needs culture passages (p10-16).
● Important bottleneck of reprogramming and directly related to differentiation 
potential.
Select good 
quality iPSC
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